BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22462121)

  • 1. Direct effect models.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2008; 4(1):Article 23. PubMed ID: 22462121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted minimum loss based estimation of causal effects of multiple time point interventions.
    van der Laan MJ; Gruber S
    Int J Biostat; 2012; 8(1):. PubMed ID: 22611591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted maximum likelihood based causal inference: Part I.
    van der Laan MJ
    Int J Biostat; 2010; 6(2):Article 2. PubMed ID: 21969992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doubly Robust and Efficient Estimation of Marginal Structural Models for the Hazard Function.
    Zheng W; Petersen M; van der Laan MJ
    Int J Biostat; 2016 May; 12(1):233-52. PubMed ID: 27227723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted maximum likelihood estimation of natural direct effects.
    Zheng W; van der Laan MJ
    Int J Biostat; 2012 Jan; 8(1):. PubMed ID: 22499725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causal inference from longitudinal studies with baseline randomization.
    Toh S; HernĂ¡n MA
    Int J Biostat; 2008 Oct; 4(1):Article 22. PubMed ID: 20231914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causal effect models for realistic individualized treatment and intention to treat rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 3. PubMed ID: 19122793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted maximum likelihood estimation for dynamic treatment regimes in sequentially randomized controlled trials.
    Chaffee PH; van der Laan MJ
    Int J Biostat; 2012 Jun; 8(1):Article 14. PubMed ID: 22740582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double robust and efficient estimation of a prognostic model for events in the presence of dependent censoring.
    Schnitzer ME; Lok JJ; Bosch RJ
    Biostatistics; 2016 Jan; 17(1):165-77. PubMed ID: 26224070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models.
    Petersen M; Schwab J; Gruber S; Blaser N; Schomaker M; van der Laan M
    J Causal Inference; 2014 Jun; 2(2):147-185. PubMed ID: 25909047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating prognostic factors into causal estimators: a comparison of methods for randomised controlled trials with a time-to-event outcome.
    Hampson LV; Metcalfe C
    Stat Med; 2012 Nov; 31(26):3073-88. PubMed ID: 22714785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomization, matching, and propensity scores in the design and analysis of experimental studies with measured baseline covariates.
    Loux TM
    Stat Med; 2015 Feb; 34(4):558-70. PubMed ID: 25384851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of separable direct and indirect effects in a continuous-time illness-death model.
    Breum MS; Munch A; Gerds TA; Martinussen T
    Lifetime Data Anal; 2024 Jan; 30(1):143-180. PubMed ID: 37270750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and efficient estimation of the natural direct effect among the untreated.
    Lendle SD; Subbaraman MS; van der Laan MJ
    Biometrics; 2013 Jun; 69(2):310-7. PubMed ID: 23607645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to hierarchical data analysis: Targeted maximum likelihood estimation for the causal effect of a cluster-level exposure.
    Balzer LB; Zheng W; van der Laan MJ; Petersen ML
    Stat Methods Med Res; 2019 Jun; 28(6):1761-1780. PubMed ID: 29921160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative performance of targeted maximum likelihood estimators.
    Porter KE; Gruber S; van der Laan MJ; Sekhon JS
    Int J Biostat; 2011; 7(1):. PubMed ID: 21931570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation based on case-control designs with known prevalence probability.
    van der Laan MJ
    Int J Biostat; 2008; 4(1):Article 17. PubMed ID: 22462152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative targeted maximum likelihood for time to event data.
    Stitelman OM; van der Laan MJ
    Int J Biostat; 2010; 6(1):Article 21. PubMed ID: 21969976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.